Figure 2 | Scientific Reports

Figure 2

From: Angiotensin 1–7 modulates molecular and cellular processes central to the pathogenesis of prostate cancer

Figure 2

The percentage of prostate cancer cells (LNCaP, DU-145, PC3) in the G0/G1, S, G2/M phases of cell cycle following exposure to Angiotensin 1–7 alone or in combination with angiotensin receptor inhibitors (I1: AT1 inhibitor - losartan; I2: AT2 inhibitor - PD123319; I3: AT1–7/MAS - A779; I4 – AT4/IRAP - HFI142) (mean ± SD; Tukey’s test: *p < 0.05).

Back to article page